How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

497 results for

Superficial Thrombophlebitis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Superficial vein thrombophlebitis

Superficial vein thrombophlebitis Superficial vein thrombophlebitis - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Superficial vein thrombophlebitis Last reviewed: February 2019 Last updated: May 2018 Summary Superficial vein thrombophlebitis (SVT) of the lower limb is most often a complication of varicose veins. Duplex ultrasonography should be performed on all patients with suspected SVT of the lower limb (...) , as concomitant deep vein thrombosis (DVT) may be present. Underlying prothrombotic conditions should be sought in cases of recurrent SVT and migratory SVT, especially in the absence of varicose veins. Anticoagulation to prevent venous thromboembolic complications (DVT or pulmonary embolism) is warranted, especially in patients with SVT near the saphenofemoral junction, or when the superficial thrombus is 5 cm or greater in length. Definition Superficial vein thrombophlebitis (SVT) refers to thrombus

2018 BMJ Best Practice

2. Treatment for superficial thrombophlebitis of the leg. (Abstract)

Treatment for superficial thrombophlebitis of the leg. The optimal treatment of superficial thrombophlebitis (ST) of the legs remains poorly defined. While improving or relieving the local painful symptoms, treatment should aim at preventing venous thromboembolism (VTE), which might complicate the natural history of ST. This is the third update of a review first published in 2007.To assess the efficacy and safety of topical, medical, and surgical treatments for ST of the leg in improving local (...) or objective diagnosis of a thrombus in a superficial vein.Two authors assessed the trials for inclusion in the review, extracted the data, and assessed the quality of the studies. Data were independently extracted from the included studies and any disagreements resolved by consensus. We assessed the quality of the evidence using the GRADE approach.We identified three additional trials (613 participants), therefore this update considered 33 studies involving 7296 people with ST of the legs. Treatment

2018 Cochrane

3. Treatment for superficial infusion thrombophlebitis of the upper extremity. Full Text available with Trip Pro

Treatment for superficial infusion thrombophlebitis of the upper extremity. Although superficial thrombophlebitis of the upper extremity represents a frequent complication of intravenous catheters inserted into the peripheral veins of the forearm or hand, no consensus exists on the optimal management of this condition in clinical practice.To summarise the evidence from randomised clinical trials (RCTs) concerning the efficacy and safety of (topical, oral or parenteral) medical therapy (...) of superficial thrombophlebitis of the upper extremity.The Cochrane Vascular Group Trials Search Co-ordinator searched the Specialised Register (last searched April 2015) and the Cochrane Register of Studies (2015, Issue 3). Clinical trials registries were searched up to April 2015.RCTs comparing any (topical, oral or parenteral) medical treatment to no intervention or placebo, or comparing two different medical interventions (e.g. a different variant scheme or regimen of the same intervention or a different

2015 Cochrane

4. Treatment of Lower Extremity Superficial Thrombophlebitis. (Abstract)

Treatment of Lower Extremity Superficial Thrombophlebitis. Which treatments for lower extremity superficial thrombophlebitis (ST) are associated with lower rates of venous thromboembolic events (VTEs) vs placebo?A dose of 2.5 mg of fondaparinux administered subcutaneously once daily for 45 days is associated with fewer cases of symptomatic VTE without an increase in major bleeding vs placebo. Low-molecular-weight heparin (LMWH) and nonsteroidal anti-inflammatory drugs (NSAIDs) are associated

2018 JAMA

5. Comparison of Heparin Quick Penetrating Solution and Diclofenac Quick Penetrating Solution for the Prevention of Superficial Thrombophlebitis Caused by Peripheral Venous Cannulation: A Randomized Double-Blind Study. Full Text available with Trip Pro

Comparison of Heparin Quick Penetrating Solution and Diclofenac Quick Penetrating Solution for the Prevention of Superficial Thrombophlebitis Caused by Peripheral Venous Cannulation: A Randomized Double-Blind Study. The association of superficial thrombophlebitis (ST) with deep-venous thrombosis varies between 6% and 44%. Thus, prevention of ST is important. The aim of this study was to compare the efficacy of topical quick penetrating solution (QPS) of heparin 1000 IU/mL versus diclofenac QPS (...) for prevention of postinfusion ST.This is a randomized, controlled, double-blind study.The study was done after ethical clearance and Clinical Trial Registry- India registration to compare 100 patients for the prevention of ST with application of heparin QPS and diclofenac QPS at regular intervals. Patients were randomized into two groups (Group H [control group] - heparin QPS group and Group D - diclofenac QPS group) and the assigned treatment was applied four times daily. The appearance of thrombophlebitis

2019 Anesthesia, essays and researches Controlled trial quality: uncertain

6. Thrombophlebitis - superficial

Thrombophlebitis - superficial Thrombophlebitis - superficial - NICE CKS Share Thrombophlebitis - superficial: Summary Superficial thrombophlebitis is a common disorder that occurs when a superficial vein becomes inflamed (phlebitis) and the blood within it clots (venous thrombosis). It may be spontaneous or be associated with one or more risk factors, such as varicose veins, intravenous cannulation, or previous superficial phlebitis. Septic thrombophlebitis occurs when superficial (...) thrombophlebitis becomes infected. It most commonly presents as a localized infection but, occasionally, this infection can spread to the rest of the body and become life threatening. Migratory thrombophlebitis is thrombophlebitis that recurs in the same vein, a different vein, or multiple veins. It is often associated with a serious underlying cause (such as cancer) and warrants further investigation. The prognosis of superficial thrombophlebitis is good. It usually settles within 3–4 weeks, although

2017 NICE Clinical Knowledge Summaries

7. Experimental Study of Phlebitis Ointment Administration in Acute Superficial Thrombophlebitis. Full Text available with Trip Pro

Experimental Study of Phlebitis Ointment Administration in Acute Superficial Thrombophlebitis. Acute superficial thrombophlebitis is a venous system disease. Animal models with mannitol induced phlebitis were treated with an orally administered "phlebitis ointment." 24 rabbits were randomly divided into 4 groups. The therapy group was treated with "phlebitis ointment" and a control group received "Mai Luo Shu Tong granules." Levels of blood TNF-α, IL-6, CRP, and IL-1β were measured. The tissue (...) inflammatory cells infiltration than the model group and upregulation of NF-КBp65 and PKC genes. The phlebitis ointment reduced the levels of necrosis factor-α, interleukin-6, C-reactive protein, and interleukin-1ß. The expressions of NF-КBp65 and PKC genes, which are the primary mechanisms underlying the development of thrombophlebitis, were improved significantly in tissues of both therapy group and control group.

2018 Evidence-based Complementary and Alternative Medicine (eCAM)

8. Systematic review: Prophylactic dose fondaparinux for 6?weeks in superficial thrombophlebitis of the legs reduces the risk for symptomatic thromboembolic complications

Systematic review: Prophylactic dose fondaparinux for 6?weeks in superficial thrombophlebitis of the legs reduces the risk for symptomatic thromboembolic complications Prophylactic dose fondaparinux for 6 weeks in superficial thrombophlebitis of the legs reduces the risk for symptomatic thromboembolic complications | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time (...) . To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Prophylactic dose fondaparinux for 6 weeks in superficial thrombophlebitis

2013 Evidence-Based Medicine

9. Pseudocellulitis Need Not be Benign: Three Cases of Superficial Migratory Thrombophlebitis with “Negative” Venous Duplex Ultrasonography Full Text available with Trip Pro

Pseudocellulitis Need Not be Benign: Three Cases of Superficial Migratory Thrombophlebitis with “Negative” Venous Duplex Ultrasonography Trousseau syndrome is a rare phenomenon in cancer patients characterized by superficial migratory thrombophlebitis. In this brief report, the authors describe three recent case presentations of patients without a prior history of cancer who were treated for cellulitis prior to be admitted to the hospital. All three patients were found to have "negative (...) " testing on venous duplex scanning. Communication with the technicians and additional clinical and laboratory evaluations confirmed Trousseau syndrome as well as an underlying hematologic cancer in each patient. Dermatologists should be aware of the diagnostic limitations in the venous duplex scanning, especially when evaluating superficial veins or areas overlying pain, and should recognize the importance of communicating with the technician performing the procedure.

2017 The Journal of clinical and aesthetic dermatology

10. Superficial Thrombophlebitis

Superficial Thrombophlebitis Superficial Thrombophlebitis Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Superficial Thrombophlebitis (...) Superficial Thrombophlebitis Aka: Superficial Thrombophlebitis , Thrombophlebitis , Superficial Venous Thrombosis From Related Chapters II. Differential Diagnosis Septic Superficial Thrombophlebitis III. Imaging Doppler DVT identified in 25% at time of Superficial Venous Thrombosis diagnosis DVT identified in 10% at 3 months after Superficial Venous Thrombosis diagnosis IV. Management: General Hot packs locally applied to Thrombophlebitis s (e.g. ) V. Management: Anticoagulation Indications Proximal

2018 FP Notebook

11. Treatment of lower extremity superficial thrombophlebitis. Full Text available with Trip Pro

Treatment of lower extremity superficial thrombophlebitis. What treatments for lower extremity superficial thrombophlebitis are associated with lower rates of venous thromboembolic events (VTE), major bleeding, and superficial venous thrombosis extension?Fondaparinux (2.5 mg) subcutaneously once daily for 45 days is associated with fewer symptomatic VTEs and lower rates of superficial venous thrombosis extension and recurrence with no increases in major bleeding compared with placebo. Low (...) -molecular-weight heparin and nonsteroidal anti-inflammatory drugs are associated with lower rates of superficial thrombophlebitis extension or recurrence, but data regarding symptomatic VTEs are inconclusive.

2014 JAMA Controlled trial quality: uncertain

12. Compression therapy after invasive treatment of superficial veins of the lower extremities

Compression therapy after invasive treatment of superficial veins of the lower extremities Compression therapy after invasive treatment of superficial veins of the lower extremities: Clinical practice guidelines of the American Venous Forum, Society for Vascular Surgery, American College of Phlebology, Society for Vascular Medicine, and International Union of Phlebology - Journal of Vascular Surgery: Venous and Lymphatic Disorders Email/Username: Password: Remember me Search JVS Journals Search (...) Terms Search within Search Access provided by Volume 7, Issue 1, Pages 17–28 Compression therapy after invasive treatment of superficial veins of the lower extremities: Clinical practice guidelines of the American Venous Forum, Society for Vascular Surgery, American College of Phlebology, Society for Vascular Medicine, and International Union of Phlebology x Fedor Lurie Affiliations Jobst Vascular Institute of Promedica, Toledo, Ohio University of Michigan, Ann Arbor, Mich Correspondence

2019 American Venous Forum

13. Treatment for superficial infusion thrombophlebitis of the upper extremity [Cochrane Protocol]

Treatment for superficial infusion thrombophlebitis of the upper extremity [Cochrane Protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2015 PROSPERO

14. Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study. Full Text available with Trip Pro

Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study. Although superficial thrombophlebitis (SVTE) is generally considered a benign, self-limited disease, accumulating evidence suggests that it often leads to more serious forms of venous thromboembolism. We reviewed the medical charts of 329 subjects with SVTE from the Cardiovascular Research Network Venous Thromboembolism cohort study to collect information

2016 Journal of Hospital Medicine

15. Prevalence of Isolated Asymptomatic Deep Vein Thrombosis in Varicose Vein Patients with Superficial Thrombophlebitis: A Single Center Experience in Japan Full Text available with Trip Pro

Prevalence of Isolated Asymptomatic Deep Vein Thrombosis in Varicose Vein Patients with Superficial Thrombophlebitis: A Single Center Experience in Japan Prevalence of asymptomatic deep vein thrombosis (DVT) in patients with primary varicose veins remains unclear.Here, we conducted a retrospective study to clarify the incidence of asymptomatic DVT in patients with varicose veins, especially focusing on those with superficial thrombophlebitis (STP).Among 431 patients with primary varicose veins

2015 Annals of vascular diseases

16. Low-level laser therapy for the treatment of superficial thrombophlebitis after chemotherapy in breast cancer patients: a case study Full Text available with Trip Pro

Low-level laser therapy for the treatment of superficial thrombophlebitis after chemotherapy in breast cancer patients: a case study [Purpose] We report the case of a breast cancer patient with superficial thrombophlebitis treated with low-level laser therapy. [Case] The patient was a 66-year-old women who developed superficial thrombophlebitis in the left upper limb after chemotherapy. She was administered 6 sessions of low-level laser therapy. [Result] Her pain score decreased by 8 points (...) . Her scores on the Patient and Observer scar Assessment Scale decreased by 18 points for the observer portion and by 26 points for the patient portion. [Conclusion] Low-level laser therapy is effective for the reduction of pain and the size of scar tissue in patients with superficial thrombophlebitis.

2015 Journal of physical therapy science

17. Review: Fondaparinux reduces VTE and recurrence in superficial thrombophlebitis of the leg. (Abstract)

Review: Fondaparinux reduces VTE and recurrence in superficial thrombophlebitis of the leg. 22910958 2012 10 19 2012 08 22 1539-3704 157 4 2012 Aug 21 Annals of internal medicine Ann. Intern. Med. ACP Journal Club: review: fondaparinux reduces VTE and recurrence in superficial thrombophlebitis of the leg. JC2-4 10.7326/0003-4819-157-4-201208210-02004 Stevens Scott M SM Intermountain Medical Center and University of Utah Murray, Utah, USA. eng Comment Journal Article United States Ann Intern Med

2012 Annals of Internal Medicine

18. Midlines and Thrombophlebitis

: Yes Device Product Not Approved or Cleared by U.S. FDA: No Pediatric Postmarket Surveillance of a Device Product: No Product Manufactured in and Exported from the U.S.: Yes Keywords provided by Amit Bahl, William Beaumont Hospitals: thrombosis superficial venous thrombosis deep venous thrombosis line related infection catheter survival Additional relevant MeSH terms: Layout table for MeSH terms Thrombosis Thrombophlebitis Embolism and Thrombosis Vascular Diseases Cardiovascular Diseases Venous (...) Midlines and Thrombophlebitis Midlines and Thrombophlebitis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Midlines and Thrombophlebitis The safety and scientific validity of this study

2018 Clinical Trials

19. Traumatic Penile Pain: A Case of Dorsal Vein Thrombophlebitis after Intercourse Full Text available with Trip Pro

Traumatic Penile Pain: A Case of Dorsal Vein Thrombophlebitis after Intercourse Dorsal Vein thrombosis, also known as Mondor's disease of the penis, is a superficial thrombophlebitis first described in the literature by Falco in 1955. Mondor's disease refers to a superficial thrombophlebitis of any locale. Diagnosis can be made clinically with palpation of a mobile, cord-like thickening on dorsum of penis without associated evidence of inflammation, infection, or dermatologic changes. Bedside (...) ultrasonography with color Doppler can aid in the diagnosis of penile thrombophlebitis by revealing a noncompressible superficial vessel with normal surrounding flow. The following case presentation details the etiology, diagnosis, and management of a particularly rare disease process.

2018 Case Reports in Emergency Medicine

20. Phlogenzym® in Patients With Acute Thrombophlebitis

& Co. KG Study Details Study Description Go to Brief Summary: Oral enzyme therapy in patients with acute superficial vein inflammation (thrombophlebitis) can serve as an additional treatment option besides standard therapy with compression stockings, common pain medication and physical treatments. This randomized, double-blinded trial compares efficacy and safety with placebo. Condition or disease Intervention/treatment Phase Thrombophlebitis Leg Drug: Phlogenzym Other: Placebo Phase 3 Detailed (...) Phlogenzym® in Patients With Acute Thrombophlebitis Phlogenzym® in Patients With Acute Thrombophlebitis - Efficacy and Tolerance - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Phlogenzym® in Patients

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>